Identification of repertoires of surface antigens on leukemias using an antibody microarray.
We have previously described a microarray of cluster of differentiation (CD) antibodies that enables concurrent determination of more than 60 CD antigens on leukocytes. This procedure does not require protein purification or labeling, or a secondary detection system. Whole cells are captured by a microarray of 10 nL antibody dots immobilized on a nitrocellulose film on a microscope slide. Distinct patterns of cell binding are observed for different leukemias or lymphomas. These haematological malignancies arise from precursor cells of T- or B-lymphocytic, or myeloid lineages of hematopoiesis. The dot patterns obtained from patients are distinct from those of peripheral blood leukocytes from normal subjects. This microarray technology has recently undergone a number of refinements. The microarray now contains more CD antibodies, and a scanner for imaging dot patterns and software for data analysis provide an extensive immunophenotype sufficient for diagnosis of common leukemias. The technology is being evaluated for diagnosis of leukemias with parallel use of conventional diagnostic criteria.
School of Molecular and Microbial Biosciences G08, University of Sydney, Sydney, NSW 2006, Australia.
Larissa
L
Belov
Pauline
P
Huang
Nicole
N
Barber
Stephen P
SP
Mulligan
Richard I
RI
Christopherson
D000906:Antibodies / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology* / Q000378:metabolism; D003101:Collodion / Q000737:chemistry; D018922:HL-60 Cells; D006801:Humans; D007938:Leukemia / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D007962:Leukocytes / Q000276:immunology*; D008223:Lymphoma / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D014212:Tretinoin / Q000494:pharmacology
D000906:Antibodies; D000954:Antigens, Surface; D014212:Tretinoin; D003101:Collodion